Literature DB >> 19738365

A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells.

Anita Bhattacharyya1, Erin McMillan, Serene I Chen, Kyle Wallace, Clive N Svendsen.   

Abstract

Down syndrome (DS) is a developmental disorder whose mental impairment is due to defective cortical development. Human neural progenitor cells (hNPCs) derived from fetal DS cortex initially produce normal numbers of neurons, but generate fewer neurons with time in culture, similar to the pattern of neurogenesis that occurs in DS in vivo. Microarray analysis of DS hNPCs at this critical time reveals gene changes indicative of defects in interneuron progenitor development. In addition, dysregulated expression of many genes involved in neural progenitor cell biology points to changes in the progenitor population and subsequent reduction in interneuron neurogenesis. Delineation of a critical period in interneuron development in DS provides a foundation for investigation of the basis of reduced neurogenesis in DS and defines a time when these progenitor cells may be amenable to therapeutic treatment. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19738365      PMCID: PMC2818457          DOI: 10.1159/000236899

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  76 in total

1.  RNA microarray analysis of channels and transporters in normal and fetal Down syndrome (trisomy 21) brain.

Authors:  G Lubec; S Y Sohn
Journal:  J Neural Transm Suppl       Date:  2003

2.  Down's syndrome: is there a decreased population of neurons?

Authors:  M H Ross; A M Galaburda; T L Kemper
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

3.  Evidence of arrest of neurogenesis and synaptogenesis in brains of patients with Down's syndrome.

Authors:  K E Wisniewski; M Laure-Kamionowska; H M Wisniewski
Journal:  N Engl J Med       Date:  1984-11-01       Impact factor: 91.245

Review 4.  Down syndrome--a disruption of homeostasis.

Authors:  B L Shapiro
Journal:  Am J Med Genet       Date:  1983-02

5.  Neurons in rhesus monkey visual cortex: systematic relation between time of origin and eventual disposition.

Authors:  P Rakic
Journal:  Science       Date:  1974-02-01       Impact factor: 47.728

Review 6.  Neuronal migration, with special reference to developing human brain: a review.

Authors:  R L Sidman; P Rakic
Journal:  Brain Res       Date:  1973-11-09       Impact factor: 3.252

7.  Mode of cell migration to the superficial layers of fetal monkey neocortex.

Authors:  P Rakic
Journal:  J Comp Neurol       Date:  1972-05       Impact factor: 3.215

8.  Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months.

Authors:  B Schmidt-Sidor; K E Wisniewski; T H Shepard; E A Sersen
Journal:  Clin Neuropathol       Date:  1990 Jul-Aug       Impact factor: 1.368

Review 9.  Human neural stem cells: a new tool for studying cortical development in Down's syndrome.

Authors:  A Bhattacharyya; C N Svendsen
Journal:  Genes Brain Behav       Date:  2003-06       Impact factor: 3.449

10.  Requirement for neurogenesis to proceed through the division of neuronal progenitors following differentiation of epidermal growth factor and fibroblast growth factor-2-responsive human neural stem cells.

Authors:  Thor Ostenfeld; Clive N Svendsen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

View more
  28 in total

1.  C21orf57 is a human homologue of bacterial YbeY proteins.

Authors:  Anubrata Ghosal; Caroline Köhrer; Vignesh M P Babu; Kinrin Yamanaka; Bryan W Davies; Asha I Jacob; Daniel J Ferullo; Charley C Gruber; Maarten Vercruysse; Graham C Walker
Journal:  Biochem Biophys Res Commun       Date:  2017-01-30       Impact factor: 3.575

2.  Quantitative MRI Analyses of Regional Brain Growth in Living Fetuses with Down Syndrome.

Authors:  Tomo Tarui; Kiho Im; Neel Madan; Rajeevi Madankumar; Brian G Skotko; Allie Schwartz; Christianne Sharr; Steven J Ralston; Rie Kitano; Shizuko Akiyama; Hyuk Jin Yun; Ellen Grant; Diana W Bianchi
Journal:  Cereb Cortex       Date:  2020-01-10       Impact factor: 5.357

3.  DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.

Authors:  Xiao-Yan Tang; Lei Xu; Jingshen Wang; Yuan Hong; Yuanyuan Wang; Qian Zhu; Da Wang; Xin-Yue Zhang; Chun-Yue Liu; Kai-Heng Fang; Xiao Han; Shihua Wang; Xin Wang; Min Xu; Anita Bhattacharyya; Xing Guo; Mingyan Lin; Yan Liu
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

4.  The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.

Authors:  Faycal Guedj; Jeroen L A Pennings; Millie A Ferres; Leah C Graham; Heather C Wick; Klaus A Miczek; Donna K Slonim; Diana W Bianchi
Journal:  Am J Med Genet A       Date:  2015-05-14       Impact factor: 2.802

5.  Gene expression changes in the MAPK pathway in both Fragile X and Down syndrome human neural progenitor cells.

Authors:  Erin L McMillan; Allison L Kamps; Samuel S Lake; Clive N Svendsen; Anita Bhattacharyya
Journal:  Am J Stem Cells       Date:  2012-06-03

6.  Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitors.

Authors:  Hanoch Kaphzan; Pepe Hernandez; Joo In Jung; Kiriana K Cowansage; Katrin Deinhardt; Moses V Chao; Ted Abel; Eric Klann
Journal:  Biol Psychiatry       Date:  2012-03-03       Impact factor: 13.382

7.  Olig1 function is required to repress dlx1/2 and interneuron production in Mammalian brain.

Authors:  John C Silbereis; Hiroko Nobuta; Hui-Hsin Tsai; Vivi M Heine; Gabriel L McKinsey; Dimphna H Meijer; Mackenzie A Howard; Magda A Petryniak; Gregory B Potter; John A Alberta; Scott C Baraban; Charles D Stiles; John L R Rubenstein; David H Rowitch
Journal:  Neuron       Date:  2014-02-05       Impact factor: 17.173

Review 8.  In vitro neurogenesis: development and functional implications of iPSC technology.

Authors:  Claudia Compagnucci; Monica Nizzardo; Stefania Corti; Ginevra Zanni; Enrico Bertini
Journal:  Cell Mol Life Sci       Date:  2013-11-20       Impact factor: 9.261

9.  Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down's syndrome.

Authors:  Gurjinder Kaur; Ajay Sharma; Wenjin Xu; Scott Gerum; Melissa J Alldred; Shivakumar Subbanna; Balapal S Basavarajappa; Monika Pawlik; Masuo Ohno; Stephen D Ginsberg; Donald A Wilson; David N Guilfoyle; Efrat Levy
Journal:  J Neurosci       Date:  2014-04-09       Impact factor: 6.167

10.  Deficits in human trisomy 21 iPSCs and neurons.

Authors:  Jason P Weick; Dustie L Held; George F Bonadurer; Matthew E Doers; Yan Liu; Chelsie Maguire; Aaron Clark; Joshua A Knackert; Katharine Molinarolo; Michael Musser; Lin Yao; Yingnan Yin; Jianfeng Lu; Xiaoqing Zhang; Su-Chun Zhang; Anita Bhattacharyya
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.